DUBLIN, Jan. 11, 2018
DUBLIN, Jan. 11, 2018 /PRNewswire/ --
The "Integrated Delivery Networks in the US" report has been added to Research and Markets' offering.
This analysis discusses the market and healthcare forces behind the creation of the IDN sector, analyzes the role of IDNs in providing care for people at different key stages of their life, and assesses the ways that IDNs tackle controlling drug costs.
Integrated delivery networks (IDNs) are a growing approach to streamlined healthcare in the US, providing support from the cradle to the care home. The formation of IDNs is driven by increases in healthcare spending and the desire to reduce costs while maintaining patient outcomes and quality of care.
Pharmaceutical companies need to adapt their sales and marketing approaches to follow the changes that have come with the development of IDNs. IDNs have different decision-making processes, the size to leverage price discussions, and access to real-world data in order to understand a drug's true value. As a result, pharmaceutical companies need to understand what IDNs want, build better value into their products, and up skill their sales teams to be able to communicate to these new and growing organizations.
Key Topics Covered:
1 EXECUTIVE SUMMARY
2 CHALLENGES IN HEALTHCARE
3 PAYMENT PRESSURES: IDNS AS A SOLUTION
4 THE GROWTH OF IDNS
5 IDNS' FOCUS
6 IDNS AND MEDICINES MANAGEMENT
7 IDNS ARE MAKING AN IMPACT ON PHARMA STRATEGY
For more information about this report visit https://www.researchandmarkets.com/research/fqw8sw/united_states?w=5
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716